Web-economic-crisis-health-systems-and-health-web
Web-economic-crisis-health-systems-and-health-web Web-economic-crisis-health-systems-and-health-web
Country profiles of health system responses to the crisis | Germany 389 Changes to health coverage Population (entitlement) • No response reported. The benefits package • New legislation (in effect since 2011) subjects all new pharmaceutical products (automatically covered upon market introduction but at a rebated price) to evaluation of their additional therapeutic benefit; new drugs that do not demonstrate additional benefit are assigned to a reference price group after six months; prices of drugs with additional benefit are negotiated based on the degree of benefit and are applied from the 13th month after market introduction. User charges • Quarterly co-payment of €10 for GP and outpatient specialist visits abolished because of the large surpluses accumulated by the SHI system (2012). Changes to health service planning, purchasing and delivery Prices of medical goods • No response reported. Salaries and motivation of health sector workers • Adjustments to the reimbursement of ambulatory physicians were frozen (2011, 2012), but an additional €1 billion was negotiated in 2011. Payment to providers • Reimbursement of psychiatric hospitals under a DRG-like system. The reimbursement rates are updated annually (by way of negotiations) (2013). Overhead costs: restructuring the Ministry of Health and purchasing agencies • No response reported. Provider infrastructure and capital investment • No response reported. Priority setting or protocols to change access to treatments, coordination of care and patterns of use • No response reported. Waiting times • No response reported. Health promotion and prevention • No response reported.
Greece Charalampos Economou and Daphne Kaitelidou Economic trends • Real GDP per capita growth was negative in 2009 and the lowest in the European region in 2010 (-5.8%) and 2011 (-6.0%). In 2009, Greece had the largest budget deficit in the European region and has since reduced government spending as a share of its economy. • Unemployment has been increasing sharply since the onset of the crisis. • Ten-year bond rates have increased throughout the crisis and were the highest in Europe in 2011. Beginning in 2010, Greece received bailout funds from the IMF and Eurozone countries. • Health spending as a share of GDP, which had been below average even before 2008, was reduced in 2011. Per capita OOP expenditure declined in 2011 by 37.0%, a notable shift in the trend (Greece: Figs 1 and 2). Policy responses Changes to public funding for the health system • MoU bailout stipulations required public spending on health to be cut by 0.5% of GDP in 2011 and to be kept below 6% of GDP in 2012; as a result, the 2011 health budget decreased by €1.9 billion; between 2009 and 2012, public spending on health fell by 25.2% (€4 billion). • The MoU stipulated a reduction in government transfers to social health insurance for civil servants, which changed from being an open-ended commitment to cover any expenditure exceeding civil servants' own contributions (2.55% of gross earnings) to a fixed contribution rate of 5.1% of gross earnings (2011). • The Public Investment Programme provided €65 million to fund policies implemented by the Ministry of Health in 2012 and €45 million for 2013. • Contributions paid by retired civil servants were increased from 2.55% to 4% (2013).
- Page 372 and 373: Country profiles of health system r
- Page 374 and 375: Country profiles of health system r
- Page 376 and 377: Country profiles of health system r
- Page 378 and 379: Country profiles of health system r
- Page 380 and 381: Country profiles of health system r
- Page 382 and 383: Bulgaria Antoniya Dimova and Mina P
- Page 384 and 385: Country profiles of health system r
- Page 386 and 387: Country profiles of health system r
- Page 388 and 389: Country profiles of health system r
- Page 390 and 391: Cyprus Elisavet Constantinou and Ma
- Page 392 and 393: Country profiles of health system r
- Page 394 and 395: Czech Republic Tomáš Roubal and J
- Page 396 and 397: Country profiles of health system r
- Page 398 and 399: Country profiles of health system r
- Page 400 and 401: Country profiles of health system r
- Page 402 and 403: Country profiles of health system r
- Page 404 and 405: Estonia Triin Habicht and Mall Lein
- Page 406 and 407: Country profiles of health system r
- Page 408 and 409: Finland Jan Klavus and Lauri Vuoren
- Page 410 and 411: Country profiles of health system r
- Page 412 and 413: France Karine Chevreul, Karen Berg
- Page 414 and 415: Country profiles of health system r
- Page 416 and 417: Country profiles of health system r
- Page 418 and 419: Country profiles of health system r
- Page 420 and 421: Germany Klaus-Dirk Henke and Wilm Q
- Page 424 and 425: Country profiles of health system r
- Page 426 and 427: Country profiles of health system r
- Page 428 and 429: Country profiles of health system r
- Page 430 and 431: Country profiles of health system r
- Page 432 and 433: Country profiles of health system r
- Page 434 and 435: Iceland Sigrún Gunnarsdóttir and
- Page 436 and 437: Country profiles of health system r
- Page 438 and 439: Ireland Anne Nolan and Steve Thomas
- Page 440 and 441: Country profiles of health system r
- Page 442 and 443: Country profiles of health system r
- Page 444 and 445: Israel Bruce Rosen and Amir Shmueli
- Page 446 and 447: Country profiles of health system r
- Page 448 and 449: Country profiles of health system r
- Page 450 and 451: Country profiles of health system r
- Page 452 and 453: Kazakhstan Ninel Kadyrova and Tata
- Page 454 and 455: Country profiles of health system r
- Page 456 and 457: Country profiles of health system r
- Page 458 and 459: Latvia Uldis Mitenbergs and Maris T
- Page 460 and 461: Country profiles of health system r
- Page 462 and 463: Country profiles of health system r
- Page 464 and 465: Country profiles of health system r
- Page 466 and 467: Country profiles of health system r
- Page 468 and 469: Country profiles of health system r
- Page 470 and 471: Malta Natasha Azzopardi Muscat Econ
Country profiles of <strong>health</strong> system responses to the <strong>crisis</strong> | Germany<br />
389<br />
Changes to <strong>health</strong> coverage<br />
Population (entitlement)<br />
• No response reported.<br />
The benefits package<br />
• New legislation (in effect since 2011) subjects all new pharmaceutical products<br />
(automatically covered upon market introduction but at a rebated price) to<br />
evaluation of their additional therapeutic benefit; new drugs that do not<br />
demonstrate additional benefit are assigned to a reference price group after six<br />
months; prices of drugs with additional benefit are negotiated based on the degree<br />
of benefit <strong>and</strong> are applied from the 13th month after market introduction.<br />
User charges<br />
• Quarterly co-payment of €10 for GP <strong>and</strong> outpatient specialist visits abolished<br />
because of the large surpluses accumulated by the SHI system (2012).<br />
Changes to <strong>health</strong> service planning, purchasing <strong>and</strong> delivery<br />
Prices of medical goods<br />
• No response reported.<br />
Salaries <strong>and</strong> motivation of <strong>health</strong> sector workers<br />
• Adjustments to the reimbursement of ambulatory physicians were frozen<br />
(2011, 2012), but an additional €1 billion was negotiated in 2011.<br />
Payment to providers<br />
• Reimbursement of psychiatric hospitals under a DRG-like system. The<br />
reimbursement rates are updated annually (by way of negotiations) (2013).<br />
Overhead costs: restructuring the Ministry of Health <strong>and</strong> purchasing agencies<br />
• No response reported.<br />
Provider infrastructure <strong>and</strong> capital investment<br />
• No response reported.<br />
Priority setting or protocols to change access to treatments, coordination<br />
of care <strong>and</strong> patterns of use<br />
• No response reported.<br />
Waiting times<br />
• No response reported.<br />
Health promotion <strong>and</strong> prevention<br />
• No response reported.